These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8527291)

  • 1. Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion.
    Cawello W; Leonhardt A; Schweer H; Seyberth HW; Bonn R; Lomeli AL
    Br J Clin Pharmacol; 1995 Sep; 40(3):273-6. PubMed ID: 8527291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects.
    Cawello W; Schweer H; Müller R; Bonn R; Seyberth HW
    Eur J Clin Pharmacol; 1994; 46(3):275-7. PubMed ID: 8070511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry.
    Schweer H; Meese CO; Watzer B; Seyberth HW
    Biol Mass Spectrom; 1994 Mar; 23(3):165-70. PubMed ID: 8148408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas chromatography/negative ion chemical ionization triple quadrupole mass spectrometric determination and pharmacokinetics of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostan oic acid in plasma.
    Schweer H; Cawello W; Seyberth HW
    Prostaglandins Leukot Essent Fatty Acids; 1994 Dec; 51(6):401-5. PubMed ID: 7708804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the metabolism of prostaglandin E1 administered intravenously to human volunteers.
    Peskar BA; Cawello W; Rogatti W; Rudofsky G
    J Physiol Pharmacol; 1991 Sep; 42(3):327-31. PubMed ID: 1793892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of prostaglandin E1, prostaglandin E0 and 15-keto-prostaglandin E0 in human plasma by gas chromatography/negative-ion chemical-ionization tandem mass spectrometry.
    Hammes W; Büchsler U; Kinder P; Bökens H
    J Chromatogr A; 1999 Jun; 847(1-2):187-202. PubMed ID: 10431360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome.
    Cox JW; Andreadis NA; Bone RC; Maunder RJ; Pullen RH; Ursprung JJ; Vassar MJ
    Am Rev Respir Dis; 1988 Jan; 137(1):5-12. PubMed ID: 3337471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH; Rudofsky G; Peskar BA
    Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.
    Leonhardt A; Schweer H; Wolf D; Seyberth HW
    Br J Clin Pharmacol; 1992 Mar; 33(3):323-5. PubMed ID: 1576056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interindividual variation in the enzymatic 15-keto-reduction of 13,14-dihydro-15-keto-prostaglandin E1 in human liver and in human erythrocytes.
    Rady-Pentek P; Mueller R; Tang BK; Kalow W
    Eur J Clin Pharmacol; 1997; 52(2):147-53. PubMed ID: 9174685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Peskar BA; Hesse WH; Rogatti W; Diehm C; Rudofsky G; Schweer H; Seyberth HW
    Prostaglandins; 1991 Mar; 41(3):225-8. PubMed ID: 1852896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E1 produces spasmolytic effects on histamine-induced bronchoconstriction in dogs.
    Hashimoto Y; Hirota K; Ohtomo N; Sato T; Ishihara H; Matsuki A
    Crit Care Med; 1999 Dec; 27(12):2755-9. PubMed ID: 10628622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing immunoaffinity chromatography (IAC) cross-reactivity in GC-MS/MS exemplified at the measurement of prostaglandin E1 in human plasma using prostaglandin E2-specific IAC columns.
    Tsikas D; Suchy MT; Tödter K; Heeren J; Scheja L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():101-107. PubMed ID: 25944643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine.
    Awas JA; Soteriou MC; Drougas JG; Stokes KA; Roberts LJ; Pinson CW
    Transplantation; 1996 Jun; 61(11):1624-9. PubMed ID: 8669108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
    Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
    Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction.
    Cawello W; Schweer H; Dietrich B; Seyberth HW; Albrecht D; Fox A; Hohmuth H
    J Urol; 1997 Oct; 158(4):1403-7. PubMed ID: 9302131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Prostaglandin E1 in dog plasma using liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.
    Zhang Y; Sun Y; Li G; Yin L; Wang T; Yang Y; Gu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():97-102. PubMed ID: 24029554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologically active levels of PGE1 in neonates with congenital heart disease.
    Leonhardt A; Kühl PG; Schweer H; Wolf D; Seyberth HW
    Acta Paediatr Scand; 1989 Nov; 78(6):853-7. PubMed ID: 2603710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostaglandin E1 on hepatic blood flow in conscious dogs with chronic biliary obstruction.
    Machiki Y; Nimura U; Kanda H; Uematsu T; Kitagawa YU; Kamiya S; Watanabe T
    Eur Surg Res; 1998; 30(2):115-24. PubMed ID: 9565745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo formation of prostaglandin E1 and prostaglandin E2 in atopic dermatitis.
    Leonhardt A; Krauss M; Gieler U; Schweer H; Happle R; Seyberth HW
    Br J Dermatol; 1997 Mar; 136(3):337-40. PubMed ID: 9115911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.